Here's something most ibogaine marketing pages bury near the bottom, if they mention it at all: this medicine can kill you. Not in a scary-story sense. In an actual, documented, cardiac-arrest sense. Ibogaine is one of the most promising tools we have for interrupting opioid addiction and shaking loose stubborn patterns of trauma — and it's also the psychedelic with the most serious medical contraindications. If you're researching whether ibogaine is right for you, understanding who shouldn't take it matters more than reading another glowing testimonial.

This isn't meant to scare anyone off. Plenty of people go through ibogaine safely every year, and for some, it's genuinely life-changing — especially those looking at plant medicine for addiction after years of trying everything else. But the difference between a safe experience and a medical emergency often comes down to screening. So let's talk about what actually disqualifies people, why, and what a responsible clinic looks like on the intake side.

Why Ibogaine Is Different From Other Psychedelics

Ayahuasca, psilocybin, San Pedro — these master plants carry their own risks, but they don't typically stress the cardiovascular system the way ibogaine does. Ibogaine has a direct effect on the heart's electrical activity. Specifically, it prolongs something called the QT interval, which is the time your heart's ventricles take to reset between beats. Prolong it too much and you're looking at a dangerous arrhythmia called torsades de pointes, which can be fatal.

That's the mechanism behind most of the deaths that have occurred in ibogaine settings over the past few decades. Not the visions. Not the purge. The heart. So when a reputable clinic asks you for an EKG, blood work, and a full medication list, they're not being paranoid — they're being competent.

The other thing worth knowing: ibogaine has a long half-life. A typical flood dose keeps you in an altered, physically demanding state for anywhere from 24 to 36 hours, with residual effects lingering for days. If something goes wrong medically at hour 18, you can't just wait it out. That's why the trend among serious providers has shifted toward medical-model clinics with cardiac monitoring, IV access, and staff who can actually intervene.

Heart Conditions: The Big Disqualifiers

Cardiac issues are the number one reason people get turned away from legitimate ibogaine programs. If any of the following apply to you, most responsible clinics will decline to treat you — and the ones that won't decline are the ones you should worry about.

• Long QT syndrome (congenital or acquired)
• Any history of arrhythmia, including atrial fibrillation
• Structural heart disease — valve problems, cardiomyopathy, congenital defects
• Coronary artery disease or previous heart attack
• Heart failure or reduced ejection fraction
• Uncontrolled high blood pressure
• Pacemaker or implantable defibrillator
• Recent cardiac surgery
• Family history of sudden cardiac death before age 50

Some of these can be worked around with additional testing and cardiology clearance. Others are absolute stops. A borderline QT reading might get you retested; a documented arrhythmia probably won't. If you're over 40 or have any risk factors, expect the clinic to want a recent EKG and often an echocardiogram before they'll even schedule you.

Medications That Don't Mix With Ibogaine

This is where things get complicated, because a huge number of common prescriptions either prolong QT themselves or interfere with the liver enzymes that metabolize ibogaine. The stack effect can be brutal.

SSRIs and SNRIs — the entire class of common antidepressants including sertraline, fluoxetine, escitalopram, venlafaxine, duloxetine — are a significant concern. Most reputable providers require a taper of several weeks before treatment. This is not optional and not something to fudge on your intake form. Combining serotonergic medications with ibogaine can trigger serotonin syndrome, which is its own medical emergency layered on top of the cardiac risk.

Other medication categories that raise red flags:

• Methadone (requires a long transition to short-acting opioids before treatment — sometimes months)
• Buprenorphine/Suboxone (also requires transition, though shorter)
• Antipsychotics, especially older ones like haloperidol
• Certain antibiotics — the fluoroquinolones and some macrolides
• Antifungals like ketoconazole and fluconazole
• Some antihistamines, particularly older ones
• MAOIs (absolute contraindication)
• Tricyclic antidepressants
• Certain anti-nausea drugs like ondansetron

The methadone situation deserves its own mention because it trips up so many people seeking ibogaine specifically for opioid addiction. Methadone stores in your tissues and comes out slowly. Attempting ibogaine while still on methadone or too soon after stopping it dramatically raises the cardiac risk. Any clinic willing to treat you the week after your last methadone dose is not a clinic you want to be at.

Other Medical Conditions Worth Flagging

Beyond heart issues and medications, several other conditions can rule someone out or require significant additional screening:

• Liver disease — ibogaine is metabolized by the liver, and impaired function changes how the body clears it. Hepatitis, cirrhosis, or elevated liver enzymes require careful evaluation.
• Kidney disease — reduced clearance means the drug hangs around longer than expected.
• Seizure disorders — ibogaine can lower the seizure threshold in susceptible people.
• Uncontrolled diabetes — the metabolic stress of a long treatment can be dangerous without careful monitoring.
• Active psychosis or a personal history of schizophrenia or bipolar I — psychedelics generally, and ibogaine specifically, can destabilize serious psychiatric conditions.
• Pregnancy or breastfeeding — no clinic worth its name will treat pregnant women.
• Severe eating disorders — the physical demands of the experience and the low body weight involved raise cardiac risk considerably.
• Recent stimulant use — cocaine, methamphetamine, and MDMA within the past several weeks all raise concerns.

Age itself isn't a hard cutoff, but most clinics get more cautious past 55 and much more cautious past 65. The heart just doesn't tolerate the stress as reliably. Some clinics won't treat anyone over 65 regardless of test results.

How to Tell If a Clinic Is Actually Screening You Properly

If you've made it this far in your research, you're already ahead of most people. Now the question becomes: how do you tell the safe providers from the reckless ones? A few honest signals to look for:

1. They ask for a recent EKG before accepting your booking, not after you arrive.
2. They require blood work — a full metabolic panel, liver function, and electrolytes at minimum.
3. They ask for a complete medication list and give you a specific taper protocol for anything that conflicts.
4. They have a medical doctor or nurse on-site during dosing, not just “nearby.”
5. They can describe what emergency equipment they have and what their protocol is if something goes wrong.
6. They've turned people down before and will tell you so.
7. They don't promise outcomes. Anyone guaranteeing sobriety, healing, or transformation is selling you something.

A clinic that says “we'll figure it out when you get here” is not a clinic. It's a liability. And unfortunately, that describes more ibogaine operations than the community likes to admit — particularly in places where medical oversight is loose and the market is booming.

What If You're Disqualified?

Getting turned down for ibogaine is disappointing, especially if you've been circling the idea for a long time and you've read the stories about opioid interruption. But it's not the end of the road for anyone considering psychedelic healing for addiction or trauma.

Ayahuasca doesn't carry the same cardiac profile, though it has its own MAOI-related medication conflicts. Psilocybin therapy — increasingly available in legal settings — has one of the cleanest safety profiles of any psychedelic. Ketamine-assisted therapy is legal, medically supervised, and effective for depression and some addiction patterns. Even conventional treatments like naltrexone or extended residential care have real evidence behind them and don't require betting on your QT interval.

The point isn't that ibogaine is the only door. It's a powerful door for people it fits, and a dangerous one for people it doesn't. Being told no by a good clinic is a form of care.

For anyone still weighing this decision and wanting to see what responsibly run programs actually look like, a curated selection of ibogaine and other plant medicine retreats can be browsed on our marketplace here. Take your time with it — the right treatment, at the right place, at the right moment in your life, is worth waiting for.